Cargando…
Development of a novel prognostic signature for predicting the overall survival of bladder cancer patients
Background: Bladder cancer is one of the most common malignancies. So far, no effective biomarker for bladder cancer prognosis has been identified. Aberrant DNA methylation is frequently observed in the bladder cancer and holds considerable promise as a biomarker for predicting the overall survival...
Autores principales: | Tang, Huamei, Kan, Lijuan, Ou, Tong, Chen, Dayang, Dou, Xiaowen, Wu, Wei, Ji, Xiang, Wang, Mengmeng, Zong, Zengyan, Mo, Hongmei, Zhang, Xiuming, Xiong, Dan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Portland Press Ltd.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7286875/ https://www.ncbi.nlm.nih.gov/pubmed/32441304 http://dx.doi.org/10.1042/BSR20194432 |
Ejemplares similares
-
LINC00958 and HOXC13-AS as key candidate biomarkers in head and neck squamous cell carcinoma by integrated bioinformatics analysis
por: Xiong, Dan, et al.
Publicado: (2020) -
Analytical performance evaluation of five RT‐PCR kits for severe acute respiratory syndrome coronavirus 2
por: Wang, Mengmeng, et al.
Publicado: (2020) -
Consistency evaluation of Liferiver, Yaneng, Darui, and the Cobas 4800 test for high‐risk human papillomavirus screening
por: Wang, Mengmeng, et al.
Publicado: (2020) -
An aberrant DNA methylation signature for predicting the prognosis of head and neck squamous cell carcinoma
por: Chen, Dayang, et al.
Publicado: (2021) -
dbCNV: deleteriousness-based model to predict pathogenicity of copy number variations
por: Lv, Kangqi, et al.
Publicado: (2023)